Stock comparison
LeMaitre Vascular
Stryker
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LMAT
LeMaitre Vascular
Market cap
$2.27B
Sector
Healthcare
SYK
Stryker
Market cap
$121.8B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LMAT | SYK | Winner |
|---|---|---|---|
| Warren Buffett | 77B | 65B | LMAT |
| Benjamin Graham | 89A | 83A | LMAT |
| Philip Fisher | 81C | 67C | LMAT |
| Peter Lynch | 67B | 68B | SYK |
| Joel Greenblatt | 56D | 50D | LMAT |
| Charlie Munger | 68D | 63D | LMAT |
| Terry Smith | 69D | 62D | LMAT |
Side-by-side metrics
| Metric | LMAT | SYK |
|---|---|---|
| Market cap | $2.27B | $121.8B |
| P/E (TTM) | 37.1x | 35.2x |
| EV/EBIT | 36.6x | 26.4x |
| ROIC (TTM) | 9.43% | 9.79% |
| Gross margin | 72.39% | 63.67% |
| Net margin | 24.35% | 13.21% |
| Revenue CAGR 5y | 12.75% | 10.07% |
| EPS CAGR 5y | 19.04% | 12.55% |
| Debt / Equity | 0.5x | 0.6x |
| Dividend yield | 0.84% | 1.12% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LMAT leads on
- Net margin24.35%vs 13.21%+46%
- EPS CAGR 5y19.04%vs 12.55%+34%
- Debt / Equity0.5xvs 0.6x+27%
- Revenue CAGR 5y12.75%vs 10.07%+21%
SYK leads on
- Market cap$121.8Bvs $2.27B+98%
- EV/EBIT26.4xvs 36.6x+28%
- Dividend yield1.12%vs 0.84%+25%
- P/E (TTM)35.2xvs 37.1x+5%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.